However, INHA remained a robust negative predictor of survival in lung adenocarcinomas patients expressing low ENG (HR = 2.12, p = 0.00041) but was not significant in ENG high expressing patients (HR = 1.25, p = 0.14) (Table 1). This evidence concerns the gene INHA and lung adenocarcinoma.